STARR CHRISTOPHER M bought MNPR
October 1, 2026 · Form 4 insider transaction
STARR CHRISTOPHER M bought 8,400 shares of Monopar Therapeutics Inc. at $0.01 per share, a transaction worth $42.00. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,400
Price
$0.01
Total value
$42.00
InsiderSTARR CHRISTOPHER M
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 1, 2026
Filing dateOctober 5, 2026
Shares owned after13,573
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 28, 2026.